Alison L. Jones

JAMA internal medicine, no. 3 (2020): 468-468

The Medical journal of Australia, no. 10 (2019): 447

Vaccine, no. 18 (2019): 2447-2454

Internal medicine journal, no. 1 (2019): 110-113

Frontiers in psychiatry, (2019): 767

European archives of psychiatry and clinical neuroscience, no. 1 (2019): 17-35

BMC psychiatry, no. 1 (2019): 117

Neuromuscular Disorders, (2019)

Internal Medicine Journal, no. 1 (2019): 110-113

Pilot and feasibility studies, no. 1 (2019): 32

Frontiers in neuroscience, (2018): 743

BMC psychiatry, no. 1 (2018): 390

Vaccine, (2018)

Drug and Alcohol Dependence, (2018): 98-111

Neuromuscular Disorders, (2018)

Clinical toxicology (Philadelphia, Pa.), pp.1-8, (2017)

Journal of The Polynesian Society, no. 1 (2017): 7-32

Neuromuscular Disorders, (2017)

Neuromuscular Disorders, (2017)

Vaccine, no. 15 (2017): 1856-1864

Vaccine, no. 20 (2017): 2745-2752

Vaccine, (2016)

PLOS ONE, no. 12 (2016)

The Annals of occupational hygiene, no. 6 (2016): 771-9

Alzheimers & Dementia, no. 7 (2016): 664

AlterNative, no. 2 (2016): 138-150

PLOS ONE, no. 3 (2016)

European Neuropsychopharmacology, (2016)

BMJ, (2015)

New Zealand Journal of Educational Studies, (2015)

British Journal of Clinical Pharmacology, (2015)

European Neuropsychopharmacology, (2014)

New Zealand Journal of Educational Studies, (2012)

CNS Drugs, no. 3 (2012): 269-276

Toxicological Reviews, no. 3 (2012): 187-194

Drug Safety, (2012)

Drug Safety, no. 9 (2012): 625-632

Drug Safety, no. 2 (2012): 125-156

New Zealand Journal of Educational Studies, (2011)

Journal of Paediatrics and Child Health, (2011)

Journal of Paediatrics and Child Health, (2010)

Journal of medical toxicology : official journal of the American College of Medical Toxicology, no. 1 (2010): 37-40

Breast Cancer Research and Treatment, no. 3 (2010): 787-794

Critical care (London, England), no. 3 (2009): 144-144

Gerontologist, (2009): 456-456

Clinical toxicology (Philadelphia, Pa.), no. 9 (2008): 855-857

British Medical Journal, no. 7630 (2007): 1154-1155

Intensive Care Medicine, no. 11 (2007): 2019-2024

The Lancet, no. 9571 (2007)

Lancet (London, England), no. 9571 (2007): 1490-1490

BMJ, (2007)

American Journal of Emergency Medicine, (2006)

Emergency Medicine Journal, (2005)

Drug Safety, no. 14 (2004): 1115-1133

Adverse Drug Reaction Bulletin, no. 229 (2004): 1-4

Emergency Medicine Journal, (2004)

Adverse Drug Reaction Bulletin, no. 228 (2004): 1-4

Seminars in Oncology, no. 5 Suppl 10 (2004): 29-34

The American journal of emergency medicine, no. 2 (2003): 121-124

Trends in Pharmacological Sciences, no. 4 (2003): 154-157

Critical care (London, England), no. 3 (2003): R1-6

Critical care (London, England), no. 2 (2002): 108-110

British Medical Journal, no. 7313 (2001): 633-633

Circulation, no. 17 (2001): 447-447

QJM: An International Journal of Medicine, no. 11 (2001): 657-658

The FASEB Journal, (2000)

BMJ, (2000): 633-633

British Journal of Cancer, (2000): 53-53

Lancet Oncology, no. 1 (2000): 61-61

Emergency Medicine Australasia, no. 1 (2000): 14-21

Toxicology, no. 1 (2000): 21-22

Educational Theory, (1999)

Clinical Toxicology, no. 4 (1998): 277-285

BMJ (Clinical research ed.), no. 7164 (1998): 1016-1016

Molecular Immunology, no. 11 (1998): 665-665

BMJ, (1997)

British Journal of Hospital Medicine, (1997)

BMJ, (1997)